UC Davis Long-Term Outcomes of the Boston Type I Keratoprosthesis Jennifer Li, M.D., Mark Greiner, M.D. Ana Carolina Vieira, M.D. Mark Mannis, M.D. University.

Slides:

Advertisements

Similar presentations

Sérgio Kwitko, Tiago Lansini, Andressa P Stolz, Diane R Marinho Authors have no financial interest in the subject matter of this poster.

Advertisements

Dohlman CH, Harissi-Dagher, M, Graney JM. The Boston Keratoprosthesis: a new threadless design. Digital Journal of Ophthalmology. Volume 13: Number.

ETIOLOGY OF KERATOPROSTHESIS LOSS: RESULTS FROM THE BOSTON KERATOPROSTHESIS MULTICENTER STUDY J.B. Ciolino, MD; J.D. Ament, MD; B.L. Zerbe, MD; M. W. Belin,

The authors have no financial disclosures relevant to the topic.

Relationship Between Donor Graft Cell Count and Visual Outcome in DSAEK Patients Authors Silvin Bakalian MD PhD, Johanna Choremis MD FRCSC, Michele Mabon.

DESCEMETIC DALK AND PREDESCEMETIC DALK : OUTCOMES IN 44 CASES DR. NITESH NARAYEN CORNEA AND REFRACTIVE SURGEON MAXIVISION HYDERABAD THE AUTHOR HAS NO FINANCIAL.

Long-Term Outcome of Corneal Transplant Surgery in Pediatric Patients with Keratoconus Anna Djougarian, MD Hofstra / North Shore-LIJ Medical Center Gerald.

Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster.

Siamak Zarei-Ghanavati M.D., FICO

Boston Type I Keratoprosthesis and Silicone Oil for the Treatment of Hypotony in Prephthisis Kristiana D. Neff 1, William I. Sawyer 2, Michael R. Petersen.

Modified Postoperative Regimen to Increase Retention of Keratoprostheses Juan Carlos Abad, MD Private practice, Medellín - Colombia Carolina Gómez Calle,

April 15-17, 2015 World Cornea Congress VII San Diego, California

Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore

Somasheila I. Murthy, Prashant Garg, Pravin K. Vaddavalli

The Second Report of The National cataract Surgery Registry PATIENTS’ CHARACTERISTICS Table 1.1: Age Distributions.

Retinal Detachment after Keratoprosthesis Placement: Incidence, Predisposing Factors, and Visual and Anatomic Outcomes M. Stephanie R. Jardeleza, M.D.

Prof. A. John Kanellopoulos, MD 1 Long-term Safety and Efficacy of High-Fluence Collagen Crosslinking of the Vehicle Cornea in.

Table 2.1.1: New Transplant Rate per million population (pmp), Year New transplants

Deep anterior lamellar keratoplasty (DALK) in Tohoku University, Japan T Hariya MD, A Kubota MD PhD, M Uematsu MD, S Yokokura MD PhD,K Nishida MD PhD,

Urrets-Zavalia Syndrome Following Descemet Stripping Endothelial Keratoplasty Claire Y. Chu, MD Pawan Prasher, MD Eric Dai, MD R. Wayne Bowman, MD V. Vinod.

1 Justin H. Townsend, MD Harry W. Flynn, Jr., MD The authors have no financial interest in the subject matter of this poster Treatment of Endophthalmitis.

Prospective Study of Intrastromal Corneal Ring Segments for Keratoconus Scott X. Stevens, MD Bend Ophthalmology, LLC Author has no financial interest.

Corneal CXL in Children With Progessive Keratoconus Author do not have any financial interest in the surgical procedure or the medicines used in this study.

Glaucoma and Penetrating Keratoplasty : Incidence, Risk Factors, and Outcomes Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.

Visual Outcomes After Temporary Keratoprosthesis Kristin C. Bains, MD Robert Phillips, MD The authors have no financial interest in the subject matter.

Postoperative Visual Acuity in Patients With Fuchs Dystrophy Undergoing Descemet Membrane–Stripping Automated Endothelial Keratoplasty: Correlation With.

Deep Anterior Lamellar Keratoplasty in Herpes Simplex Corneal Opacities V. Sarnicola Italy ASCRS-ASOA ANNUAL MEETING Boston April 9-14, 2010.

Assessing the Role of Soft Contact Lenses in Preoperative Conditions Following Keratoprosthesis Implantation The authors have no financial interest in.

Indications for and Outcomes of Therapeutic Penetrating Keratoplasty Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author has no.

Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting.

Endothelial Dystrophy Association with Hyperopia Glenn W. Thompson, M.D. Timothy P. Page, M.D. Authors have no financial interest.

Wait time and Vision and Health Problems in Adults Expecting Corneal Transplantation at a Hospital in Montreal, Canada M Alizadeh-Ebadi MD, H Boisjoly.

“Tuck In” Lamellar Keratoplasty (TILK) for Post-Keratoplasty Corneal Ectasia involving the Corneal Periphery Vishal Jhanji, MD 1,2 Jacqueline Beltz, MBBS,

AlphaCor TM : A Novel Approach to Minimize Late Post-operative Complications V. Ngakeng MD, M. Price PhD. MBA, F. Price MD.

INSTITUTO DE OJOS Dr. HUGO DANIEL NANO Buenos Aires, Argentina No financial disclosures to discuss.

Combined Phacoemulsification and Ahmed Glaucoma Drainage Implant Surgery Leonidas Traipe, M.D. Felipe Valenzuela, M.D. Carlos Nieme, M.D Juan Stoppel,

1 Clinical Outcomes of DSEK Surgery Combined With Other Intraocular Procedures Neil Mahesh Vyas, MD Fei Yu, PhD Anthony J. Aldave, MD Sophie Deng, MD,

Sergio Kwitko, Andressa P. Stolz, Melissa Dal Pizzol, Diane Marinho, Samuel Rymer Ophthalmology Department - Hospital de Clínicas de Porto Alegre Federal.

Clinical outcome of DALK in Keratoconus – A one year follow up

E-Poster Price Vision Group & Cornea Research Foundation of America Descemet - Stripping Endothelial Keratoplasty :Survival Outcomes in Eyes with Pre-

Tiago Lansini, MD ; Sergio Kwitko, PhD Authors have no financial interest in the subject matter of this poster.

Miguel A. López M.D., María A. González Reiley M.D. The authors have no financial interest in the subject matter of this poster.

REFRACTIVE OUTCOMES WITH TORIC ICL IMPLANTS CHIEF AUTHOR: Dr. D.RAMAMURTHY CO – AUTHOR: Dr. R.CHITRA The authors have no financial interest in the subject.

Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,

*Kagithane State Hospital,Department of Ophthalmology,Istanbul, Turkey DR.GÖKHAN KAYA *Kagithane State Hospital,Department of Ophthalmology, No author.

Evaluation of Efficacy and Safety of Intracorneal Ring Segment (Intacs SK) in Keratoconus Abdulrahman Al-Muammar, MD, FRCSC I have no financial interest.

Visual and IOP Outcomes after PRK in Pigment Dispersion Syndrome [Poster Number: P190] Kraig S. Bower, Denise A. Sediq, Charles D. Coe, Keith Wroblewski,

Efficacy and Safety of the Ex-PRESS Glaucoma Mini-Shunt with Intraoperative 5-Fluorouracil ASCRS 2009 – San Francisco A. Balashanmugam, MD, L. Farrokh-Siar,

Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.

Corneal Tattooing with Amniotic Membrane Woo Chan Park M.D., Won Yeol Ryu M.D. Dept. of Ophthalmology, College of Medicine, Dong-A University Busan, Korea.

DSEK for the treatment of endothelial disease in India -Initial Experience in 80 eyes- Authors have no financial interest Dr Ashish Nagpal MD, FRCS Dr.

Yonca Aydin Akova MD, Leyla Erkanli Asena MD

First 25 Descemet Membrane Endothelial Keratoplasty (DMEK) Outcomes for an Experienced DSAEK Surgeon Authors: Victoria Epstein, MS.,DO, Josh Wallsh, MS-III,

EXPERIENCE WITH A PMMA KERATOPROSTHESIS AT THE FEDERAL UNIVERSITY OF SAO PAULO, BRASIL Oliveira LA, M.D; Sousa LB, M.D; Hofling-Lima AL, M.D; Freitas D,

The Use of a PMMA Keratoprosthesis in Severe Ocular Chemical Burn Fabiano Cade, Allyson Tauber, Claes H. Dohlman Massachusetts Eye and Ear Infirmary Harvard.

Descemet’s Stripping Endothelial Keratoplasty (DSEK) in patients with prior Trabeculectomy or Tube shunt surgery. Thadani S.M. Fynn-Thompson N. Authors.

Cost-Effectiveness of the Type II Boston Keratoprosthesis Jared D. Ament, MD, MPH, Tomasz P. Stryjewski, BS, Siddharth Pujari, PhD, George Papaliodus,

F. Knoll, D. C. Ritterband, C. Y. Shih, I. J. Udell, J. A. Seedor The authors have no financial interest in the subject matter of this poster. A Comparative.

Outcomes and Complications of DSEK in Eyes with Tube shunts or ACIOLs

World Cornea Congress VI April 7-9, 2010

Modified Osteo-Odonto Keratoprosthesis (MOOKP) in patients with severe anterior segment disease: Our Hong Kong Experience Bone – Tooth Cornea replacement.

Endothelial keratoplasty in failed grafts

Kyoto Prefectural University of Medicine

Hong A, Boehlke CS, Afshari NA, Kim T Duke University Medical Center

Long term Results of Endothelial Keratoplasty in patients with failed penetrating Keratoplasty Maoz D. Amiran, MD, Raneen Shehadeh-Mashor, MD, Marie Eve.

O Beltaief, Kh Errais, W Zbiba, A Ouertani.

Outcomes Post Laser-In-Situ Keratomileusis in HIV+ Patient Population

Francis Char DeCroos, MD

Presentation transcript:

UC Davis Long-Term Outcomes of the Boston Type I Keratoprosthesis Jennifer Li, M.D., Mark Greiner, M.D. Ana Carolina Vieira, M.D. Mark Mannis, M.D. University of California, Davis Sacramento, California The authors have no financial interest in the subject matter of this poster.

UC Davis Study Purpose To evaluate long-term outcomes after placement of Boston type 1 keratoprosthesis To determine the types and frequency of complications that may develop postoperatively

UC Davis Materials and Methods A retrospective chart review of all Boston type 1 keratoprosthesis surgeries performed at a single institution (UC Davis) beginning in May, 2004 through January, 2010

UC Davis Boston Keratoprosthesis UC Davis, Demographics Number of eyes40 Number of patients35 Average age 52.9 years (range 2-86 years) Gender 57% M 43% F Average follow-up time30.1 months

UC Davis Patient Demographics Preoperative Corneal Diagnosis# Eyes (%)Avg. # Prior PKPs Chemical burn10 (25.0%)1.6 Failed graft NOS7 (17.5%)2.3 Aniridia5 (12.5%)1.6 Keratoconus4 (10.0%)3.0 HSV4 (10.0%)2.5 Congenital hereditary endothelial dystrophy 2 (5.0%)1.0 Other Thermal burn, Apert’s syndrome, ocular cicatricial pemphigoid, Peters, Stevens-Johnson, rheumatoid arthritis, Fuchs endothelial dystrophy, HLA-B27 uveitis 8 (20.0%)2.3 Total40 (100%)2.0

UC Davis Preoperative BCVA

UC Davis Preoperative Glaucoma Number of eyes with glaucoma (%) 23 (57.5%) Average number of preop glaucoma medications 1.52 Number of eyes with prior glaucoma surgery (%) 14 (35%)

UC Davis Preoperative versus Postoperative BCVA

UC Davis Postoperative BCVA Changes: Comparing pre-op to final post-op BCVA

UC Davis Postoperative Complications Complications of K-Pro# Eyes (%) Retroprosthetic membrane22 (55.0%) YAG laser membranectomy10 (25.0%) Surgical membranectomy5 (12.5%) Endophthalmitis5 (12.5%) Glaucoma31 (77.5%) * Progression11 (27.5%) GDD placement (excluding concomitant GDDs) 1 (2.5%) GDD erosion8 (20.0%) ** Transscleral cyclophotocoagulation2 (5.0%) Endocyclophotocoagulation3 (7.5%) End-stage glaucoma7 (17.5%) Corneal melt with K-Pro extrusion6 (15.0%) Replacement of K-Pro7 (17.5%) Removal of K-Pro3 (7.5%) **7 of 8 GDD erosions required revision and/or removal of device. *23 (57.5%) had preoperative glaucoma diagnosis.

UC Davis Retroprosthetic Membrane Exposed Tube Shunt Periprosthetic Infiltrate Extrusion of Keratoprosthesis

UC Davis Conclusions High percentage of patients have long-term BCVA equal to or better than pre-operative visual acuity There is a moderately high percentage of patients with long-term complications status post Boston type 1 keratoprosthesis placement Progression of glaucoma and complications related to glaucoma can be visually devastating Although many patients may benefit from keratoprosthesis placement, long-term visual prognosis is guarded. Successful management of these patients requires pre- and post-operative collaboration with glaucoma and vitreoretinal specialists Further study is needed to determine the best means of managing postoperative glaucoma